10. Vetoquinol S.A. – Top 10 animal health companies

A cow and dog touching noses

Vetoquinol logoVetoquinol S.A.
2015 Revenue: $374.5 million (€342.6 million)
HQ: Lure Cedex, France

Vetoquinol made a major growth push in 2014, when it acquired the animal health business of Canada-based Bioniche Life Sciences. Vetoquinol’s catalog now includes a wide range of products for dogs, cats, livestock and horses. In 2015, its sales for companion animals were particularly strong, rising nearly 11%, thanks to new products such as Upcard, a drug approved in Europe to treat congestive heart failure in dogs. The company also launched Permacyl, a treatment approved in Europe to treat mastitis in cows. Strong sales of new products helped offset a decline in demand for antibiotics stemming from tightened regulations in the U.S. and other countries that are aimed at stopping the rise of drug-resistant infections. Vetoquinol CEO Matthieu Frechin is looking for opportunities to expand the company’s footprint, vowing in its year-end earnings release to remain “proactive” in assessing acquisition opportunities.

Related Articles: 
Vétoquinol rides reference products sales in second quarter

10. Vetoquinol S.A. – Top 10 animal health companies
Read more on

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…